Cargando…

P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON-HODGKIN’S LYMPHOMA DURING COVID-19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES

Detalles Bibliográficos
Autores principales: Galusic, D., Basic - Kinda, S., Pijuk, A., Milunovic, V., Dreta, B., Franjic, N., Coha, B., Sincic – Petricevic, J., Gacina, P., Pejsa, V., Lucijanic, M., Aurer, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429116/
http://dx.doi.org/10.1097/01.HS9.0000847308.18096.87
_version_ 1784779335413006336
author Galusic, D.
Basic - Kinda, S.
Pijuk, A.
Milunovic, V.
Dreta, B.
Franjic, N.
Coha, B.
Sincic – Petricevic, J.
Gacina, P.
Pejsa, V.
Lucijanic, M.
Aurer, I.
author_facet Galusic, D.
Basic - Kinda, S.
Pijuk, A.
Milunovic, V.
Dreta, B.
Franjic, N.
Coha, B.
Sincic – Petricevic, J.
Gacina, P.
Pejsa, V.
Lucijanic, M.
Aurer, I.
author_sort Galusic, D.
collection PubMed
description
format Online
Article
Text
id pubmed-9429116
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94291162022-08-31 P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON-HODGKIN’S LYMPHOMA DURING COVID-19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES Galusic, D. Basic - Kinda, S. Pijuk, A. Milunovic, V. Dreta, B. Franjic, N. Coha, B. Sincic – Petricevic, J. Gacina, P. Pejsa, V. Lucijanic, M. Aurer, I. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429116/ http://dx.doi.org/10.1097/01.HS9.0000847308.18096.87 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Galusic, D.
Basic - Kinda, S.
Pijuk, A.
Milunovic, V.
Dreta, B.
Franjic, N.
Coha, B.
Sincic – Petricevic, J.
Gacina, P.
Pejsa, V.
Lucijanic, M.
Aurer, I.
P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON-HODGKIN’S LYMPHOMA DURING COVID-19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES
title P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON-HODGKIN’S LYMPHOMA DURING COVID-19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES
title_full P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON-HODGKIN’S LYMPHOMA DURING COVID-19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES
title_fullStr P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON-HODGKIN’S LYMPHOMA DURING COVID-19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES
title_full_unstemmed P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON-HODGKIN’S LYMPHOMA DURING COVID-19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES
title_short P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON-HODGKIN’S LYMPHOMA DURING COVID-19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES
title_sort p1110: efficacy and safety of immunochemotherapy in treatment of follicular non-hodgkin’s lymphoma during covid-19 pandemic: a study of krohem, the croatian cooperative group for hematologic diseases
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429116/
http://dx.doi.org/10.1097/01.HS9.0000847308.18096.87
work_keys_str_mv AT galusicd p1110efficacyandsafetyofimmunochemotherapyintreatmentoffollicularnonhodgkinslymphomaduringcovid19pandemicastudyofkrohemthecroatiancooperativegroupforhematologicdiseases
AT basickindas p1110efficacyandsafetyofimmunochemotherapyintreatmentoffollicularnonhodgkinslymphomaduringcovid19pandemicastudyofkrohemthecroatiancooperativegroupforhematologicdiseases
AT pijuka p1110efficacyandsafetyofimmunochemotherapyintreatmentoffollicularnonhodgkinslymphomaduringcovid19pandemicastudyofkrohemthecroatiancooperativegroupforhematologicdiseases
AT milunovicv p1110efficacyandsafetyofimmunochemotherapyintreatmentoffollicularnonhodgkinslymphomaduringcovid19pandemicastudyofkrohemthecroatiancooperativegroupforhematologicdiseases
AT dretab p1110efficacyandsafetyofimmunochemotherapyintreatmentoffollicularnonhodgkinslymphomaduringcovid19pandemicastudyofkrohemthecroatiancooperativegroupforhematologicdiseases
AT franjicn p1110efficacyandsafetyofimmunochemotherapyintreatmentoffollicularnonhodgkinslymphomaduringcovid19pandemicastudyofkrohemthecroatiancooperativegroupforhematologicdiseases
AT cohab p1110efficacyandsafetyofimmunochemotherapyintreatmentoffollicularnonhodgkinslymphomaduringcovid19pandemicastudyofkrohemthecroatiancooperativegroupforhematologicdiseases
AT sincicpetricevicj p1110efficacyandsafetyofimmunochemotherapyintreatmentoffollicularnonhodgkinslymphomaduringcovid19pandemicastudyofkrohemthecroatiancooperativegroupforhematologicdiseases
AT gacinap p1110efficacyandsafetyofimmunochemotherapyintreatmentoffollicularnonhodgkinslymphomaduringcovid19pandemicastudyofkrohemthecroatiancooperativegroupforhematologicdiseases
AT pejsav p1110efficacyandsafetyofimmunochemotherapyintreatmentoffollicularnonhodgkinslymphomaduringcovid19pandemicastudyofkrohemthecroatiancooperativegroupforhematologicdiseases
AT lucijanicm p1110efficacyandsafetyofimmunochemotherapyintreatmentoffollicularnonhodgkinslymphomaduringcovid19pandemicastudyofkrohemthecroatiancooperativegroupforhematologicdiseases
AT aureri p1110efficacyandsafetyofimmunochemotherapyintreatmentoffollicularnonhodgkinslymphomaduringcovid19pandemicastudyofkrohemthecroatiancooperativegroupforhematologicdiseases